Quarry »

Fate Therapeutics shares owned by Quarry

Quarter-by-quarter ownership of Fate Therapeutics (FATE) shares owned by Quarry from 13F filings

Historical chart of Quarry investment in Fate Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Fate Therapeutics held by Quarry consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Fate Therapeutics by Quarry

Quarter filed Position value Share count Share price at filing
2026-06-30 $689 255 2.70
2024-03-31 $22k 3.0k 7.34

More positions owned by Quarry

Space Exploration Techn Corp Class A Com Stk (SPCX)
Marvell Technology (MRVL)
Cornerstone Strategic Value (CLM)
Chart Industries (GTLS)
Warner Bros Discovery Com Ser A (WBD)
Kenvue (KVUE)
Penumbra (PEN)
Norfolk Southern (NSC)
Cornerstone Total Rtrn Fd In (CRF)
Roku Com Cl A (ROKU)
UniFirst Corporation (UNF)
Topbuild
Cantor Equity Partners I Shs Cl A (CEPO)
Inflection Pt Acquisition Cl A Ord Shs (IPCX)
Qorvo (QRVO)

View all positions for Quarry

Top funds holding Fate Therapeutics

Redmile Group
BlackRock
Vanguard Portfolio Management
Vanguard Capital Management
Acadian Asset Management
AQR Capital Management
Two Sigma Investments
Johnson & Johnson
Renaissance Technologies
Millennium Management
State Street Corporation
Goldman Sachs Group
Geode Capital Management
Jane Street
Citadel Advisors

View all funds holding Fate Therapeutics